DeepSeek rocks the Magnificent 7, and a tonic for Fever Tree shareholders?

from Companies And Markets Weekly · host Stockopedia

In this week’s episode, Lawrence is joined by Graham Neary and Megan Boxall. They discuss:02:20 - Fevertree #FEVR - can its recent strategic partnership with Molson Coors put the fizz back in its investment case?11:54 - WH Smith #SMWH - we discuss the sale of its high street business, and whether there’s a potential opportunity for it to re-rate as a lower-debt travel business.18:33 - PayPoint #PAY - this week’s trading update from one of the UK’s “best fintech stocks”, and what value are shareholders really getting from its buyback scheme?28:12 - AJ Bell #AJB - why its seemingly positive update this week may have disappointed the market.35:09 - Why Graham is so downbeat on #SAGA’s prospects, despite the refinancing of its corporate debt this week.37:55 - Whether the Magnificent 7 can continue to justify their sky-high valuations after quarterly earnings from this week, and the AI giants’ tussle with DeepSeek. Where could you find potentially better opportunities?If you enjoyed this, you can read daily analysis on noteworthy and hard-to-research shares with Stockopedia’s Daily Stock Market Report. You’ll also unlock award-winning investing insights, tools, and education to speed up your research process and help you make more informed decisions.Try Stockopedia free for 14 days at stk.pe/pod.Extra Stockopedia content we mention:Ahead of Expectations: How trading updates drive share price momentum: https://www.stockopedia.com/academy/reports/ahead-of-expectations-how-trading-updates-drive-share-price-momentum/Host: Lawrence JuddAnalysts: Megan Boxall, Graham NearyHelp us improve the podcast by leaving your feedback here: https://www.surveymonkey.com/r/XLRXBP5Disclaimer: We do not provide personalised financial advice. None of our content constitutes or should be understood as constituting a recommendation to enter in any securities transactions or to engage in any investment strategies discussed in our content. We do not provide personalised recommendations or views as to whether a stock or investment approach is suited to the financial needs of a specific individual. It is very important to do your own analysis before making any investment based on your own personal circumstances.

What this episode covers

In this week's episode, Lawrence is joined by Graham Neary and Megan Boxall. They discuss: 02:20 - Fevertree #FEVR - can its recent strategic partnership with Molson Coors put the fizz back in its investment case? 11:54 - WH Smith #SMWH - we discuss the sale of its high street business, and whether there's a potential opportunity for it to re-rate as a lower-debt travel business. 18:33 - PayPoint #PAY - this week's trading update from one of the UK's "best fintech stocks", and what value are shareholders really getting from its buyback scheme? 28:12 - AJ Bell #AJB - why its seemingly positive update this week may have disappointed the market. 35:09 - Why Graham is so downbeat on #SAGA's prospects, despite the refinancing of its corporate debt this week. 37:55 - Whether the Magnificent 7 can continue to justify their sky-high valuations after quarterly earnings from this week, and the AI giants' tussle with DeepSeek. Where could you find potentially better opportunities? If you enjoyed this, you can read daily analysis on noteworthy and hard-to-research shares with Stockopedia's Daily Stock Market Report. You'll also unlock award-winning investing insights, tools, and education to speed up your research process and help you make more informed decisions. Try Stockopedia free for 14 days at stk.pe/pod [https://stk.pe/pod]. Extra Stockopedia content we mention: Ahead of Expectations: How trading updates drive share price momentum: https://www.stockopedia.com/academy/reports/ahead-of-expectations-how-trading-updates-drive-share-price-momentum/ Host: Lawrence Judd Analysts: Megan Boxall, Graham Neary Help us improve the podcast by leaving your feedback here: https://www.surveymonkey.com/r/XLRXBP5 Disclaimer: We do not provide personalised financial advice. None of our content constitutes or should be understood as constituting a recommendation to enter in any securities transactions or to engage in any investment strategies discussed in our content. We do not provide personalised recommendations or views as to whether a stock or investment approach is suited to the financial needs of a specific individual. It is very important to do your own analysis before making any investment based on your own personal circumstances.